Terry Gehlhausen
Family Medicine · Oakland City, INNPI 1861479743
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 24.4% of the total. Reporting peaked in 2020 at $660 and has fallen 87.3% since, to $84 in 2025.
Across 95 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$411
- AstraZeneca$310
- Otsuka America Pharmaceutical, Inc.$163
- Eisai Inc.$118
- Lilly USA, LLC$86
- Mylan Specialty L.p.$76
- plus $520 from 16 others
What the payments were for
- Food & beverage$1,685100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 26 | $411 |
| AstraZeneca | 17 | $310 |
| Otsuka America Pharmaceutical, Inc. | 2 | $163 |
| Eisai Inc. | 4 | $118 |
| Lilly USA, LLC | 6 | $86 |
| Mylan Specialty L.p. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $66 |
| Medtronic | 1 | $52 |
| Pfizer | 4 | $52 |
| Amgen | 4 | $51 |
| Johnson & Johnson | 3 | $40 |
| Astellas Pharma US Inc | 3 | $38 |
| GSK | 3 | $35 |
| Nestle Healthcare Nutrition Inc. | 2 | $31 |
| Novartis | 2 | $27 |
| Amarin Pharma, Inc. | 2 | $24 |
| Boehringer Ingelheim | 2 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
How this compares
$1,685 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imatinib Mesylate | 13 | $71,176 |
| EliquisApixaban | 226 | $66,742 |
| OzempicSemaglutide | 64 | $65,682 |
| JardianceEmpagliflozin | 185 | $58,312 |
| OxycontinOxycodone Hcl | 30 | $26,790 |
| FarxigaDapagliflozin Propanediol | 82 | $23,814 |
| XareltoRivaroxaban | 80 | $22,087 |
| Memantine Hcl | 172 | $18,529 |
| MyrbetriqMirabegron | 78 | $17,574 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 75 | $17,022 |
| RexultiBrexpiprazole | 15 | $13,249 |
| Tresiba Flextouch U-100Insulin Degludec | 35 | $12,761 |
| Divalproex Sodium | 125 | $12,442 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 121 | $12,257 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 39 | $11,676 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $22 | $69,885226 claims |
| PfizerEliquis | $52 | $66,742226 claims |
| Novo NordiskOzempic | $411 | $65,68264 claims |
| AstraZenecaFarxiga | $310 | $23,81482 claims |
| Johnson & JohnsonXarelto | $40 | $22,08780 claims |
| Astellas Pharma US IncMyrbetriq | $38 | $17,57478 claims |
| GSKArexvy, Incruse Ellipta | $35 | $15,85068 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $163 | $13,24915 claims |
| NovartisEntresto | $27 | $11,05129 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $20 | $10,99326 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Oakland City
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.